GEN inCode is a company that specializes in risk assessment and prediction of cardiovascular diseases, thrombosis, and familial hypercholesterolemia. Its online reporting system SITAB helps to select the optimal treatment pathway and informs patients about possible cardiovascular perils. The company combines traditional clinical measures and patients’ genetic information to assess a comprehensive risk and gives clinical recommendations.